Voice therapy, PD-COMM

What’s it about?
The primary objective of the trial is to evaluate the clinical and cost-effectiveness of the two types of Speech and Language Therapy (SLT) against no treatment (the  control group) for people with Parkinson’s. The trial will also compare  Lee Siverman Voice Treatment (LSVT) with the standard NHS SLT.

Where is it?
Exeter, Torbay, and across Somerset. In elderly care or neurology units or in the community (according to local practice).

How long does it take?
Your involvement is spread over a 12 month period. Following a period of treatment (except for the control group) you will report by post afterwards.

Who is eligible?
Anyone with a diagnosis of Parkinson’s of any age who reports problems with voice or speech, BUT you must not have received LSVT within the last 2 years.

What does it involve?
You will be randomly assigned to either of the treatments or NO treatment (the control group).
LSVT will be administered in 4 sessions per week for 4 weeks of pre-determined content with homework.
NHS SLT will have more variability but typically will be 1 session per week for 6 – 8 weeks of varying content as determined by participant need.
You will complete an assessment before being randomly assigned,  and then by post at 3, 6 and 12 months after that point.

Patient Information Sheet      Carer Information Sheet

How do I enrol?
Contact the Trial Coordinator, Pui Au
Tel 0121 415 9126
email p.au@bham.ac.uk
This Trial is being led by the Birmingham Clinical Trials Unit at 42 locations around the UK. The recruitment target is 546 people.